Offer - Urjas Oil for just ₹ 1
Tyrokinin 150 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
The optimal dosage of Tyrokinin 150 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Tyrokinin 150 Tablet have been listed ahead. Usually, these side effects of Tyrokinin 150 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Tyrokinin 150 Tablet's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Tyrokinin 150 Tablet related warnings talks about Tyrokinin 150 Tablet's effects on the liver, heart and kidney.
Tyrokinin 150 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tyrokinin 150 Tablet in conditions like Liver Disease, Kidney Disease, Lung Disease. Other conditions have been mentioned below in the Tyrokinin 150 Tablet contraindications section.
Drug interactions for Tyrokinin 150 Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Tyrokinin 150 Tablet is considered not safe while driving, and is not addictive.
Tyrokinin 150 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tyrokinin 150 Tablet safe for pregnant women?
Tyrokinin may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Tyrokinin again without your doctor's advice.
Is the use of Tyrokinin 150 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Tyrokinin. If you see any side effects, stop taking Tyrokinin immediately and talk to your doctor. Take Tyrokinin again, only after your doctor's advice.
What is the effect of Tyrokinin 150 Tablet on the Kidneys?
Using Tyrokinin does not have any harmful effects on kidneys.
What is the effect of Tyrokinin 150 Tablet on the Liver?
Tyrokinin can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Tyrokinin 150 Tablet on the Heart?
Using Tyrokinin does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Tyrokinin 150 Tablet unless your doctor advises you to do so -
Is this Tyrokinin 150 Tablet habit forming or addictive?
No, there is no any evidence that Tyrokinin 150 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tyrokinin 150 Tablet, you should not drive or work on any heavy machine, as Tyrokinin 150 Tablet can make you drowsy.
Is it safe?
Tyrokinin 150 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Tyrokinin 150 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Tyrokinin 150 Tablet
Taking Tyrokinin 150 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Tyrokinin 150 Tablet
Due to lack of research, there is no information about the side effects of taking Tyrokinin 150 Tablet with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516